股票代码：002747 股票简称：埃斯顿 公告编号：2025-040 号 南京埃斯顿自动化股份有限公司 关于使用部分闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、进行现金管理的审批情况 南京埃斯顿自动化股份有限公司（以下简称"公司"）分别于第五届董事会 第十三次会议、第五届监事会第十二次会议、2024 年年度股东大会审议通过了 《关于公司及子公司使用部分闲置自有资金进行现金管理的议案》，同意公司及 子公司拟对最高余额不超过人民币 10 亿元的闲置自有资金适时进行现金管理， 投资于流动性好、安全性高的中、低风险理财产品；在上述额度内可滚动使用暂 时闲置的自有资金进行现金管理。公司及子公司应严格遵守审慎投资原则，选择 银行、证券公司等金融机构的中、低风险短期的投资品种，以及进行结构性存款、 大额存单、国债逆回购、收益凭证、资管计划等方式的短期现金管理。具体内容 详 见 2025 年 4 月 29 日 、 2025 年 5 月 22 日 披 露 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）的相 ...

Core Viewpoint - The issuance of the "Notice" aims to accelerate the application and development of intelligent elderly care service robots in response to the increasing challenges of population aging through policy guidance and resource integration [3][4]. Summary by Relevant Sections Event - On June 9, 2025, the Ministry of Industry and Information Technology and the Ministry of Civil Affairs jointly released the "Notice on Conducting Pairing Attacks and Scene Application Pilot Work for Intelligent Elderly Care Service Robots" [2]. Main Content - The "Notice" emphasizes three main areas: 1. Establishing partnerships between enterprises and elderly care institutions to address five major needs, including disability care and emotional companionship, while overcoming shortcomings in safety and reliability. 2. Conducting scene application verification, requiring 200 households to validate home scenarios and deploying over 200 sets of equipment; for community/institution scenarios, covering more than 20 communities or elderly care institutions with at least 20 sets of equipment, with a verification period of no less than six months. 3. Improving standards and evaluation systems, requiring pilot units to jointly formulate standards for aging suitability and safety evaluation to enhance product reliability and intelligence [3][4]. Background - The aging process in China is deepening, with the population aged 60 and above expected to exceed 300 million by the end of 2024, accounting for 22% of the total population. There is a shortage of 5.5 million elderly care workers, particularly for disabled elderly care needs. The elderly care robot market has significant potential, but two core issues must be addressed: low public awareness and high product prices, along with insufficient intelligence [4]. - The silver economy is projected to reach approximately 7 trillion yuan in 2024, accounting for 6% of GDP, and is expected to grow to 30 trillion yuan by 2035, representing 10% of GDP. The domestic elderly care robot market is anticipated to exceed 30 billion yuan in 2024 and reach 50 billion yuan in 2025, with a compound annual growth rate of over 30% [4]. Investment Suggestions - The policy aims to bridge the gap between technology and commercialization, transitioning the elderly care robot industry from "concept innovation" to "scale application." The industry is recommended for attention, with specific stocks suggested for consideration [5][6].

Group 1 - The concept of elderly care robots is gaining traction, with significant movements in related ETFs, particularly the largest robot ETF in the Shenzhen market, which saw a trading volume exceeding 1.1 billion yuan and a 0.34% increase [1] - The ETF has experienced a net inflow of nearly 120 million yuan over the past two days, indicating strong investor interest [1] - The Ministry of Industry and Information Technology and the Ministry of Civil Affairs have initiated a pilot program for intelligent elderly care service robots, requiring at least 200 household applications and deployments of 200 units [1] Group 2 - The humanoid robot industry chain is continuously evolving, with advancements in hardware, components, algorithms, and application scenarios, maintaining a high level of industry vitality [2] - The competition in the hardware segment is intensifying, leading to rapid cost reductions for components like screws and reducers, but also resulting in a deteriorating competitive landscape before the industry fully scales [2] - Investment opportunities in the "AI + robotics" sector are highlighted, focusing on areas such as sensors, dexterous hands, robotic dogs, exoskeletons, and specialized applications, which are not solely dependent on humanoid robots [2] - The humanoid robot industry is expected to open up broader market opportunities, potentially surpassing the automotive sector, marking a significant investment opportunity from "0 to 1" [2]

Core Viewpoint - Estun, a leading domestic industrial robot company, plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy, accelerate overseas business development, and improve its international brand image [1][2][3] Financial Performance - In 2024, Estun reported a revenue of 4.009 billion yuan, a year-on-year decrease of 13.83%, and a net loss of 810 million yuan, marking the first loss since its IPO [1][9] - The company's overseas revenue was 1.37 billion yuan in 2024, down 14.1% year-on-year, accounting for approximately 34.2% of total revenue [4][9] - The gross margin for 2024 was 32.66%, an increase of 1.4 percentage points compared to the previous year [4] Historical Context - Estun was listed on the A-share market in March 2015, with revenues and net profits increasing from 483 million yuan and 51.19 million yuan in 2015 to 1.461 billion yuan and 101 million yuan in 2018 [6] - The company achieved its highest revenue and net profit post-IPO in 2022, with figures of 3.881 billion yuan and 166 million yuan, respectively [8] Recent Challenges - In 2023, Estun's performance declined again, leading to the significant losses reported in 2024 [9] - The company attributed its losses to lower-than-expected revenue, increased operating expenses, and challenges faced by its subsidiaries, which resulted in goodwill impairment totaling 345 million yuan [9][10] Future Plans - Estun aims to expand its global business, focusing on markets in Europe, America, the Middle East, and Southeast Asia, particularly targeting opportunities with leading domestic clients in the new energy and lithium battery sectors [3][9]

Core Viewpoint - Nanjing Estun Automation Co., Ltd. is taking significant steps towards listing on the Hong Kong Stock Exchange after experiencing substantial losses over the past decade, aiming to enhance its global strategy and international brand image [1][3]. Group 1: Company Overview - Estun focuses on two main business segments: automation core components and motion control systems, as well as industrial robots and intelligent manufacturing systems [3]. - The company has been a leading domestic brand in the shipment of industrial robots in China, particularly in the multi-joint industrial robot segment [3]. Group 2: Financial Performance - In 2024, Estun reported a revenue of 4.009 billion yuan, a year-on-year decline of 13.83%. The revenue from industrial robots and intelligent manufacturing systems was 3.032 billion yuan, down 16.04%, while the automation core components segment generated 976 million yuan, down 6.13% [3]. - The company faced a significant loss of 810 million yuan in net profit attributable to shareholders, marking its first major loss since its listing in March 2015 [3]. - The decline in revenue and gross margin, along with increased operating expenses, particularly personnel costs, and impairment provisions, contributed to the losses [3]. Group 3: Strategic Initiatives - Estun's management has outlined a strategy for returning to profitability in 2025, focusing on global expansion, strategic focus, technological breakthroughs, and operational efficiency [4]. - Specific measures include optimizing the marketing system, expanding business channels, increasing R&D investment, actively pursuing overseas markets, and enhancing internal management to reduce costs and improve efficiency [4]. Group 4: Shareholding Structure - As of the end of Q1 2025, Nanjing Paili Technology Co., Ltd. is the controlling shareholder of Estun, holding 29.4% of the shares, while Chairman Wu Bo holds 12.8% [4].

Investment Rating - The report assigns a 12-month rating of "Sell" for Estun Automation with a price target of Rmb10.30, while the current price is Rmb19.38 [4][23]. Core Insights - Estun Automation has set net income targets of Rmb100 million, Rmb120 million, and Rmb140 million for the years 2025, 2026, and 2027 respectively, which may bolster investor confidence regarding its recovery from previous net losses [3]. - The company is planning an H-share listing as part of its globalization strategy and to enhance business development [2][3]. Financial Metrics - The company’s market capitalization is Rmb16.9 billion (approximately US$2.34 billion) with 870 million shares outstanding [4]. - Revenue projections show growth from Rmb4.918 billion in 2024E to Rmb8.108 billion by 2028E [6]. - Net earnings are expected to improve from Rmb8 million in 2024E to Rmb332 million by 2028E [6]. - The average daily trading volume is approximately 28,889 thousand shares, with an average daily value of Rmb626.3 million [4]. Profitability and Valuation - The EBIT margin is projected to increase from 1.8% in 2024E to 6.0% by 2028E, indicating improving profitability [6]. - The company’s net debt to EBITDA ratio is forecasted to be 10.4x in 2024E, suggesting a high level of leverage [4]. - The P/E ratio is expected to decrease from a non-measurable (NM) status in 2024E to 50.8x by 2028E [6]. Company Overview - Estun Automation, founded in 1993, specializes in CNC systems, AC servos, industrial robots, and intelligent manufacturing, positioning itself as a leading domestic manufacturer in high-end intelligent equipment [8].

Group 1 - Weijie Chuangxin plans to reduce its shareholding by up to 3%, amounting to no more than 12.91 million shares, due to personal funding needs [1] - Lier Chemical's major shareholder intends to reduce its stake by up to 3%, equivalent to no more than 24.01 million shares, for investment returns [1] - Helin Micro-Nano's controlling shareholder plans to reduce its shareholding by up to 1.5%, which is no more than 1.75 million shares, due to personal funding needs [2] Group 2 - Yifan Pharmaceutical received drug registration certificates for two products, indicating a focus on oncology and leukemia treatments [3] - *ST Jinbi is planning a change in control, leading to a temporary suspension of its stock trading [4] - Kexing Pharmaceutical's shareholder plans to reduce its stake by up to 3%, amounting to no more than 5.90 million shares, to optimize the equity structure [7] Group 3 - Li New Energy plans to invest approximately 1.25 billion yuan in three independent energy storage projects [7] - Kingsoft Office intends to acquire the remaining 31.98% stake in its subsidiary for 254 million yuan, aiming for full ownership [8] - Northeast Pharmaceutical received a CEP certificate from the European Medicines Agency for an antibiotic raw material, enhancing its product credibility [9] Group 4 - Tai'er Co. announced the lifting of a detention order on its controlling shareholder, changing it to a notice of supervision [10] - Runjian Co. won a bid for a solar power project worth approximately 83.92 million yuan, highlighting its role in the energy sector [11] - Jiuan Medical plans to register and issue medium-term notes and short-term financing bonds, with a total scale of up to 35 billion yuan and 5 billion yuan respectively [12] Group 5 - Wanma Co.'s chairman resigned due to work adjustments, but will remain as a board member [13] - Changhua Chemical plans to transfer 1% of its shares through an inquiry transfer method due to personal funding needs [14] - Jinkai Biotechnology's two shareholders plan to reduce their combined stake by up to 4%, totaling 481.6 thousand shares [15] Group 6 - Aeston plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [16] - Maiwei Biotechnology's chairman proposed a share buyback plan with a total amount between 25 million and 50 million yuan [17] - Montai High-tech's specific shareholders and executives plan to reduce their stake by up to 3.03%, citing personal funding needs [18] Group 7 - *ST Dongjing's stock will resume trading after a change in control, with a new actual controller [20] - Tongdahai's major shareholders plan to reduce their combined stake by up to 3.57%, totaling 345.24 thousand shares [23]

Core Viewpoint - The company, Estun, plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy, accelerate overseas business development, and improve its international brand image and core competitiveness [1][2]. Group 1: H-Share Issuance and Listing - Estun's board approved the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange during meetings held on June 3, 2025 [1]. - The company has appointed KPMG Hong Kong as the auditing firm for this issuance and listing [1]. - The issuance and listing are subject to approval from the shareholders' meeting and various regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange, indicating significant uncertainty regarding the implementation [2]. Group 2: Financial Performance - In 2024, Estun reported a revenue of 4.009 billion yuan, a decrease of 13.83% compared to the previous year [4][5]. - The net profit attributable to shareholders was -810.44 million yuan, a decline of 700.14% from a profit of 135.04 million yuan in the previous year [4][5]. - The net profit after excluding non-recurring gains and losses was -835.67 million yuan, compared to a profit of 85.00 million yuan in the previous year [4][5]. - The net cash flow from operating activities was -73.58 million yuan, a significant drop of 346.29% from a positive cash flow of 29.88 million yuan in the previous year [4][5].

Market Overview - US stock indices closed mixed, with the Dow Jones down 0.22%, Nasdaq up 0.32%, and S&P 500 up 0.01% [2] - Major tech stocks showed varied performance, with Meta rising over 3% and Tesla falling over 3% [2] - The Nasdaq Golden Dragon China Index rose 2.04%, with notable gains in Chinese stocks like NIO and Alibaba [2] European Market - Major European indices closed higher, with Germany's DAX up 0.7%, France's CAC40 up 0.58%, and the UK's FTSE 100 up 0.16% [3] Urban Renewal Support - The central government plans to allocate over 20 billion yuan to support urban renewal actions in 20 cities, including Beijing and Tianjin, to address infrastructure shortcomings [4] AI Industry Development - The Ministry of Industry and Information Technology is focusing on promoting the AI industry and its integration into new industrialization, emphasizing a collaborative approach to strategy and policy implementation [5] New Power System Initiatives - The National Energy Administration announced pilot projects for new power system construction, focusing on various innovative technologies and models [6] Autonomous Driving Standards - A proposal for a mandatory national standard on safety requirements for intelligent connected vehicle driving assistance systems is under consideration [7] Virtual Asset Derivatives in Hong Kong - The Hong Kong Securities and Futures Commission is considering introducing virtual asset derivatives trading for professional investors, aiming to enhance market product offerings [8] HPV Vaccine Approval - China's first nine-valent HPV vaccine has been approved for market release, breaking a long-standing foreign monopoly [9] Quantum Communication Breakthrough - A Chinese research team has successfully completed module-level verification of a star-ground quantum direct communication system, marking a significant advancement in quantum communication technology [10] Economic Outlook - The Federal Reserve's latest Beige Book indicates a slight decline in US economic activity, with rising policy uncertainty and inflationary pressures affecting businesses and consumers [11] Tesla Sales Decline - Tesla's sales in China for May fell by 15% year-on-year, amidst a broader increase in the new energy vehicle market [26]

Group 1 - The company, Estun, plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its global strategy and enhance its international brand image and core competitiveness [1] - Estun's main business segments include automation core components, motion control systems, industrial robots, and intelligent manufacturing systems, targeting various industries such as new energy, automotive, and logistics [1] - The company aims to achieve a 20% year-on-year growth in industrial robot shipments in 2024, outperforming the industry growth rate, and ranks second in China's industrial robot market by shipment volume [1] Group 2 - In 2023, Estun has accelerated its international development strategy, establishing 75 service outlets globally, and has obtained various international safety certifications [2] - The company's overseas sales revenue for 2024 is projected to be 1.37 billion yuan, a 14.1% decline year-on-year, accounting for 34.16% of total revenue [2] - Estun plans to expand into markets in Europe, America, the Middle East, and Southeast Asia, focusing on opportunities with leading domestic clients in the new energy and lithium battery sectors [2] Group 3 - In Q1 2025, Estun achieved a revenue of 1.244 billion yuan, a year-on-year increase of 24.03%, and a net profit of 12.63 million yuan, up 93.43% year-on-year [3] - The company's market share in industrial robots increased, achieving the top position in China's robot market shipments for the first time [3]